BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 10189393)

  • 1. Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects.
    Porta C; Caporali R; Montecucco C
    Haematologica; 1999 Mar; 84(3):260-9. PubMed ID: 10189393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity in thrombotic thrombocytopenic purpura.
    Porta C; Caporali R; Montecucco C
    Semin Thromb Hemost; 2005 Dec; 31(6):633-40. PubMed ID: 16388414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.
    Raife TJ; Friedman KD; Dwyre DM
    Transfusion; 2006 Jan; 46(1):74-9. PubMed ID: 16398733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired thrombotic thrombocytopenic purpura as the presenting symptom of systemic lupus erythematosus. Successful treatment with plasma exchange and immunosuppression--report of two cases.
    Starck M; Abedinpour F; Dendorfer U; Wagner-Czekalla J; Pachmann M; Mann JF; Nerl C
    Eur J Haematol; 2005 Nov; 75(5):436-40. PubMed ID: 16191095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease].
    Coppo P; Veyradier A; Monge M;
    Presse Med; 2006 Dec; 35(12 Pt 2):1876-86. PubMed ID: 17159713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.
    Tsai HM
    Kidney Int Suppl; 2009 Feb; (112):S11-4. PubMed ID: 19180123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.
    Rieger M; Mannucci PM; Kremer Hovinga JA; Herzog A; Gerstenbauer G; Konetschny C; Zimmermann K; Scharrer I; Peyvandi F; Galbusera M; Remuzzi G; Böhm M; Plaimauer B; Lämmle B; Scheiflinger F
    Blood; 2005 Aug; 106(4):1262-7. PubMed ID: 15890682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome.
    George JN
    Curr Hematol Rep; 2005 May; 4(3):167-9. PubMed ID: 15865866
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response.
    Schaller M; Studt JD; Voorberg J; Kremer Hovinga JA
    Hamostaseologie; 2013 May; 33(2):121-30. PubMed ID: 23443151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura.
    Pimanda JE; Chesterman CN; Hogg PJ
    Eur J Haematol; 2003 Apr; 70(4):257-62. PubMed ID: 12656756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura.
    Lämmle B; Kremer Hovinga J; Studt JD; Mansouri Taleghani B; Alberio L
    Hematol J; 2004; 5 Suppl 3():S6-11. PubMed ID: 15190269
    [No Abstract]   [Full Text] [Related]  

  • 13. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura and adult onset Still's disease.
    Gopal M; Cohn CD; McEntire MR; Alperin JB
    Am J Med Sci; 2009 May; 337(5):373-6. PubMed ID: 19322066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing paradigm of thrombotic thrombocytopenic purpura.
    Raife TJ
    Semin Thromb Hemost; 2005 Dec; 31(6):641-51. PubMed ID: 16388415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.
    Rock G; Anderson D; Clark W; Leblond P; Palmer D; Sternbach M; Sutton D; Wells G; ;
    Br J Haematol; 2005 Apr; 129(1):79-86. PubMed ID: 15801959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD(+)(4)CD(+)(25) Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients.
    Huang H; Sun W; Liang Y; Long XD; Peng Y; Liu Z; Wen X; Jia M
    Ren Fail; 2014 Sep; 36(8):1263-7. PubMed ID: 24990576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: effective treatment with plasma exchange and immunosuppression.
    Hess DC; Sethi K; Awad E
    J Rheumatol; 1992 Sep; 19(9):1474-8. PubMed ID: 1433020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells.
    Praprotnik S; Blank M; Levy Y; Tavor S; Boffa MC; Weksler B; Eldor A; Shoenfeld Y
    Int Immunol; 2001 Feb; 13(2):203-10. PubMed ID: 11157853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombotic thrombocytopenic purpura - a rare cause of thrombocytopenia in systemic lupus erythematosus].
    Natusch A; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1881-5. PubMed ID: 12226787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.